ArticlePharmaceutics2026

Cycloastragenol Provides Pharmacokinetic Advantages over Astragaloside IV with Enhanced Cochlear Exposure and Protection Against Age-Associated Hearing Dysfunction.

Yaqian Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.